SCHEMBL6741447

SCHEMBL6741447

COc1ccc(COc2cc[c]cc2)c(OC)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.51
CA2 P00918 2/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
IDO1 P14902 2/20 0.42
ALDH1A1 P00352 2/20 0.40
MAPT P10636 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPK1 P28482 1/20 0.40
ABCB1 P08183 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP1B1 Q16678 1/20 0.40
ADRA1A P35348 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5535297 0.83 CA12 (0.38) APLNRCA2CA12CA1CA7
SCHEMBL11571607 0.82 APLNR (0.53) APLNRCA2CA12CA1CA7
SCHEMBL920917 0.80 IDO1 (0.53) IDO1ALDH1A1MAPTABCB1ADRA1A
SCHEMBL5972609 0.79 APLNR (0.50) APLNRCA2CA12CA1CA7
SCHEMBL11571132 0.78 APLNR (0.53) APLNRCA2CA12CA1CA7
SCHEMBL4586965 0.78 SMN1; SMN2 (0.38) TSHR
Hydrochloric Acid SCHEMBL11572437 0.77 APLNR (0.51) APLNRCA2CA12CA1CA7
SCHEMBL5998553 0.77 APLNR (0.63) APLNRCA2CA12CA1CA7
SCHEMBL4003210 0.77 APLNR (0.63) APLNRCA2CA12CA1CA7
SCHEMBL873803 0.76 TUBB1 (0.40) TDP1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689771-B2 TREATMENT OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, PERIODONTITIS, GINGIVITIS, CORNEAL ULCERATION, SOLID TUMOR GROWTH BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-02-10 US disclosed